Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 672

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 6
Chunk 672
---
 10-K.

    Number
     
    Description

    3.1
     
    Third
    Amended and Restated Articles of Incorporation of MIRA Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.1 to Form S-1
    filed July 28, 2023).
  
    3.2
     
    Amended
    and Restated Bylaws of MIRA Pharmaceuticals, Inc. (incorporated by reference to Exhibit 3.3 to Form S-1 filed July 28, 2023).
  
    4.1
     
    Common
    Stock Purchase Warrant, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference to
    Exhibit 4.2 to Form S-1 filed July 28, 2023).
  
    4.2
     
    Common
    Stock Purchase Warrant from the Company to MIRALOGX, dated November 15, 2023 (incorporated by reference to Exhibit 10.2 to the Current
    Report on Form 8-K filed November 20, 2023).
  
    4.3
     
    Representative’s
    Warrant, dated August 7, 2023 (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed August
    7, 2023).
  
    4.4*
     
    Description of Securities of the Registrant
  
    10.1+
     
    2022
    Omnibus Incentive Plan, as amended and restated (incorporated by reference to Exhibit 10.1 to Form S-1 filed July 28, 2023).
  
    10.2+
     
    Form
    of Stock Option Award under 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.2 to Form S-1 filed July 28, 2023).
  
    10.3
     
    Form
    of Indemnification Agreement (incorporated by reference to Exhibit 10.3 to Form S-1 filed July 28, 2023).
  
    10.4
     
    Confirmatory
    Patent Assignment and Royalty Agreement, dated November 1, 2021, between SR